Midatech Receives Manufacturing License in Spain for its Nanoparticles

06-Jun-2011 - Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, announced that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art ...

Midatech Group and MonoSol Rx Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

Potential to Develop New Oral Drug Candidates with Superior Efficacy, Safety, Convenience, and Commercial Potential

10-Nov-2008 - Midatech Group and MonoSol Rx announced a partnership to develop new drug formulations combining biocompatible nanoparticles and PharmFilm delivery technologies. Under terms of the agreement, Midatech Ltd and MonoSol Rx will jointly research, develop and commercialize new drug candidates ...

Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles

15-May-2007 - Midatech Group Ltd, producer of nanoparticles for therapeutic and diagnostic applications, has announced the opening of its specialist design and manufacturing facility for cGMP grade nanoparticles in Bilbao, Spain. According to the company, Midatech Biogune S.L. is the world's first cGMP grade ...